214 results on '"Plentz, Ruben"'
Search Results
2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
6. Therapeutic effects of Argyrin F in pancreatic adenocarcinoma
7. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
8. Clinical presentation, risk factors and staging systems of cholangiocarcinoma
9. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
10. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
11. Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinoma
12. A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
13. Gamma‐Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt‐Beta‐Catenin Pathways in CD44+ Gastric Cancer Stem Cells
14. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms – Kurzversion 2.00 – Juni 2021, AWMF-Registernummer: 032-053OL
15. Inhibition of γ-Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma
16. Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression
17. A mouse to human search for plasma proteome changes associated with pancreatic tumor development
18. Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition
19. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma
20. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
21. Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma
22. Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition
23. Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma
24. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis
25. Hepatocellular carcinoma and octreotide: Treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage
26. Telomere Shortening Correlates With Increasing Aneuploidy of Chromosome 8 in Human Hepatocellular Carcinoma*
27. PROSPECTIVE ANALYSIS OF GERMAN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION WITH OR WITHOUT PROPHYLACTIC ANTIBIOTIC THERAPY
28. Clinical features, etiology, and survival of hepatocellular carcinoma among different countries
29. Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma.
30. Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
31. Effect of AdipoR agonist in cholangiocarcinoma.
32. The Structure Elucidation of Haprolid
33. Correction: Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis
34. Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis
35. A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
36. Primäre Lebertumoren
37. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines
38. Treatment of pancreatic ductal adenocarcinoma (PDAC) by argyrin F (AF) + gemcitabine (G).
39. Notch and wnt-beta catenin pathways as targets of γ-secretase inhibitor IX (GSI) mediated therapy in CD44+ gastric cancer (GC) cells.
40. Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma
41. Future Therapy of Cholangiocarcinoma
42. Systemic Therapy of Cholangiocarcinoma
43. The Structure Elucidation of Haprolid.
44. Early Detection of Hepatocellular Carcinoma: How to Screen and Follow up Patients with Liver Cirrhosis According to the GERMAN S3 Guideline?
45. Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors
46. Argyrin F therapy attenuates carcinogenesis of pancreatic ductal adenocarcinoma (PDAC)
47. Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine
48. Scarring mucous membrane pemphigoid presenting as double stenosis of the larynx and esophagus: precautions during therapy can avoid complications
49. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.
50. Analysis of second-line chemotherapies for ductal pancreatic adenocarcinoma in a German single-center cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.